Question 1

Who are the top researchers at Polyphor (Switzerland)?

Accepted Answer

Ranked on the quality score, Daniel Obrecht, Philipp Ermert and Debra K. S. Barker lead among researchers whose main affiliation is Polyphor (Switzerland).

Question 2

What are the most cited papers from Polyphor (Switzerland)?

Accepted Answer

The most cited paper from Polyphor (Switzerland) is "Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa" (Nityakalyani Srinivas et al., 2010), with 557 citations. Next come "Chimeric peptidomimetic antibiotics against Gram-negative bacteria" (319) and "The Role of Neutrophil Elastase Inhibitors in Lung Diseases" (225).

Question 3

Which research topics does Polyphor (Switzerland) publish most on?

Accepted Answer

By volume in 2022-now: Supply Chain Resilience and Risk Management, Risk Management in Financial Firms, Crystallography and molecular interactions and Global Healthcare and Medical Tourism.

Question 4

Which keywords describe research at Polyphor (Switzerland)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Drug Discovery, Inflammation, Host Defense, Angiogenesis, Therapeutic Targets, Cancer Metastasis, Chemokine Receptors and Macrocycles.

Question 5

Which fields of science does Polyphor (Switzerland) work in?

Accepted Answer

In all years, 43% of research at Polyphor (Switzerland) is in Health Sciences, 30% in Life Sciences. Its largest fields are Medicine (42%), Biochemistry, Genetics and Molecular Biology (23%), Chemistry (14%). It does 1.8× the world's share of Life Sciences.

Question 6

Is Polyphor (Switzerland)'s research output growing?

Accepted Answer

Output in 2022-2025 was 72% lower than in 2018-2021.